Speaker Profile

Ph.D., Product manager, Microbiome & Metabolomics, DNA Genotek Inc

Biography
Ms. Breton joined DNA Genotek in 2015, starting in the customer facing team and later moving into product management. Using her years of experience working with researchers in human genomics and microbiome, she currently leads product management for microbiome and metabolomics devices. During her PhD, Ms. Breton studied chemical and microbial signatures of forensically relevant samples in collaboration with Dr. Rob Knight's laboratory. She has previous experience as an environmental microbiologist and is a member of the Canadian College of Microbiologists.


Microbial Profiling Showcase:
DNA Genotek Inc

DNA Genotek Inc., Novosanis and Diversigen are subsidiaries of OraSure Technologies, Inc. working to provide high-quality sample collection products and comprehensive services for sample processing, sequencing, and bioinformatic analysis. Our solutions enable microbiome discovery for academic, pharmaceutical, biotechnology, agricultural and environmental applications.

OMNIgene.SKIN - A Validated Skin Microbiome Collection System
Low biomass samples like those obtained from human skin are a challenge to collect and analyze. OMNIgene®•SKIN is the first skin sampling device validated for microbiome applications with demonstrated ambient temperature stability and reliable profiling.

 Session Abstract – PMWC 2022 Silicon Valley


Track Chair:
Manoj Dadlani, CosmosID

Understanding mechanism of action and translating microbiome science into commercially viable therapeutics remains the biggest challenge in this emerging field. With that said, pharma and biotech across many different therapeutic indications and modalities are united in this global effort to bring novel microbiome-based therapies and diagnostics into the clinical domain. This session will include some of the most impactful and promising areas of the Microbiome field and panel discussions on the challenges for faster adoption.

    Sessions:
  • Regulatory Perspective
    - Scott Jackson, NIST
  • Pharma Drug Development
    Session Chair: Karim Dabbagh, Second Genome
    - Matthew Henn, Seres
    - Rangaprasad Sarangarajan, Metabolon
  • AI in Microbiome
    - Kaja Milanowska-Zabel, Ardigen
  • Direct-To-Consumer Testing/Technologies
    Session Chair: Nathan D. Price, Onegevity
    - Kiran Krishnan, Microbiome Labs
    - Nicole Scott, Cybele Microbiome
  • Microbiome and Cancer
    - Sandrine Miller-Montgomery, Micronoma
  • The Role of the Human Gut Microbiome on Various Diseases
    - Colleen Cutcliffe, Pendulum Therapeutics
    - Tor Savidge, Baylor College of Medicine
    - Nikole Kimes, Siolta Therapeutics
    - Sarkis Mazmanian, Caltech
  • The Gut/Brain Microbiome
    - Mary Conrad, Axial Biotherapeutics
    - Christopher Reyes, Bloom Science
  • Synthetic Biology in Microbiome
    - Jeff Hasty, UCSD
  • Showcase
    - Heloise Breton, DNA Genotek